Target intelligence / Profile preview

SID1 transmembrane family member 2 (SIDT2)

Target
SIDT2
Molecular classification
Lysosomal integral membrane protein, Transporter (putative nucleic acid transporter), Hydrolase (putative ceramidase activity), CREST superfamily member
01

Overview

SID1 transmembrane family member 2 (SIDT2) is a highly glycosylated lysosomal membrane protein implicated in the transport of RNA and DNA across the lysosomal membrane during nucleic acid autophagy, as well as in the hydrolysis of certain lipids[1][2][3]. SIDT2 has a structural core reminiscent of hydrolases in the CREST superfamily and forms a dimer with eleven transmembrane helices per protomer[1]. It acts as a putative nucleic acid transporter essential for lysosomal nucleic acid degradation, immune activation through antiviral cytokine production, and cellular metabolism of lipids and glucose[1][2][3]. SIDT2 is expressed in metabolically active tissues such as the liver, brain, and kidney, and its deficiency has been linked to metabolic, cardiovascular, inflammatory, and neurodegenerative disorders[1][3]. Although not a canonical drug target with approved therapeutics, it is of strong interest due to its fundamental roles in autophagy, immune response, and metabolism[1][2][3][6].

Other names
CGI-40PSEC0072UNQ685/PRO1325SIDT2SID1 transmembrane family member 2
02

Mechanism of action

Not established for drugs; functionally implicated in nucleic acid and lipid transport/hydrolysis, immune activation, and metabolic regulation[1][2][3].

03

Biological functions

Nucleic acid transport (RNA/DNA across lysosomal membrane)Autophagy (RNA and DNA autophagy)Lysosomal membrane stabilizationLipid metabolism (including ceramide hydrolysis)Insulin secretion regulationImmune response (antiviral defense and cytokine production)Regulation of glucose metabolismRegulation of mitochondrial quality controlSignal regulation
04

Disease associations

Cardiovascular disease (premature coronary artery disease, HDL cholesterol levels)Metabolic disease (lipid metabolism disorders, hepatic steatosis, insulin secretion impairment, glucose intolerance)Cancer (tumor development, chemo-resistance)Neurodegenerative disease (Alzheimer’s and Parkinson’s disease)Infection (antiviral defense, impaired cytokine production in viral infections)Inflammation
05

Safety considerations

Knockout or deficiency leads to metabolic disruptions (hyperlipidemia, hepatic steatosis), impaired antiviral response, glucose intolerance, and neurodegenerative changes[1][2][3].Potential risk in lysosomal and autophagic function disruption.
06

Biomarkers

Potential: High-density lipoprotein cholesterol levelsglucose metabolisminsulin secretion markerslipid droplet accumulation[1]

Beyond the preview

Go deeper on SID1 transmembrane family member 2 (SIDT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SID1 transmembrane family member 2 (SIDT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call